Method of treating cataracts caused by active oxygen

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514912, A61K 3144

Patent

active

053691121

ABSTRACT:
Pyrrolo quinoline esters, oxazopyrrolo quinolines and esters of oxazopyrrolo quinolines are effective at treating cataracts through their active oxygen scavenging activity.

REFERENCES:
patent: 4898870 (1990-02-01), Narutomi
"Collection of Summaries of Lectures (5) at 109th Meeting of Japan Pharmacological Society", p. 42, 1989.
"Current Therapeutic Research", 44:891-901 1988.
"PQQ and Quinoprotein", Jongejan, Duine, ed. pp. 162-164 (1989), Kluwer Academic Publishers.
"Life Science" 45: 593-398 (1989).
"Hiroshima J. Med. Sci" 38(1): 49-51 (1987).
Chem Abst. vol. 110, No. 4, Jan. 23, 1989 Abst. #29104N.
Chem Abst vol. 110, No. 10, Mar. 6, 1989, Abst #82492P.
Hamagishi et al, The Journal of Pharmacology and Experimental Therapeutics 255(3): 980-985, 1990.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating cataracts caused by active oxygen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating cataracts caused by active oxygen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cataracts caused by active oxygen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-74317

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.